MedPath

The effect of black cumin on non alcholic fatty liver

Phase 2
Conditions
on alcholic fatty liver.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT2017012232109N1
Lead Sponsor
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

patients aged 20 to 60 years diagnosed with nonalcoholic fatty liver by ultrasound, confirmed by a radiologist and a gastroenterologist.

Exclusion criteria: pregnancy and lactation; liver transplantation; smoking; alcohol and drug abuse; consuming drugs such as corticosteroids, amiodarone, tamoxifen, methotrexate; receiving total parenteral nutrition; rapid weight loss; diabetes; heart failure; thyroid problems; kidney disease; hereditary hemochromatosis and Wilson disease; have a positive test for hepatitis C, B and autoimmune hepatitis; alpha-1 antitrypsin deficiency.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tumor necrosis factor. Timepoint: before and 8 weeks after intervention. Method of measurement: ELISA.;Interleukin 6. Timepoint: before and 8 weeks after intervention. Method of measurement: ELISA.;Liver enzymes(aspartate aminotransfrase,alanin aminotransferase,gama glutamil transferase). Timepoint: before and 8 weeks after intervention. Method of measurement: Labratory kits.;C reactive protein. Timepoint: before and 8 weeks after intervention. Method of measurement: ELISA.;Lipid profiles(triglycrid,HDL,LDL and total chollestrol). Timepoint: before and 8 weeks after intervention. Method of measurement: Labratory kits.;Insulin. Timepoint: before and 8 weeks after intervention. Method of measurement: ELISA.;Fast blood sugar. Timepoint: before and 8 weeks after intervention. Method of measurement: Enzymatic chlorometric method.
Secondary Outcome Measures
NameTimeMethod
Waist to hip ratio. Timepoint: before and 8 weeks after intervention. Method of measurement: Inelastic tape without putting pressure on the body.;Body mass index. Timepoint: before and 8 weeks after intervention. Method of measurement: The ratio of weight in kilograms by the square of height in meters.;Systolic and diastolic blood pressure. Timepoint: before and 8 weeks after intervention. Method of measurement: Sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath